MedPath

Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study

Not Applicable
Active, not recruiting
Conditions
Prostate Cancer
Interventions
Behavioral: Cognitive behavioral therapy (supportive counseling)
Behavioral: Virtual Cardiac Rehabilitation
Registration Number
NCT05099679
Lead Sponsor
Stanford University
Brief Summary

Pilot study to determine the feasibility of providing psychosocial and cardiac rehabilitation services to address socioeconomic health disparities and improve wellbeing for black men with prostate cancer.

Detailed Description

Subjects will see an oncology Associate Clinical Social Worker at Stanford's Cancer Center for a two hour psychosocial assessment. Subsequently participants will complete the psychosocial intake support session and elective additional counseling sessions (Part A) at the end of up to 8 counseling sessions (maximum sessions possible) or 20 weeks (+/- 4 weeks), whichever comes first. For participants who continue onto cardiac services (Part B), the participant will complete the cardiac rehabilitation exercise program within 12 weeks (+/- 2 weeks) of the first day of exercise start. The end of study will occur after the last cardiac rehabilitation exercise session (+ 2 weeks).

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Male
Target Recruitment
14
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Psychosocial intervention + Cardiac Rehab ServicesCognitive behavioral therapy (supportive counseling)Cognitive Behavioral Therapy + Cardiac Rehab
Psychosocial intervention + Cardiac Rehab ServicesVirtual Cardiac RehabilitationCognitive Behavioral Therapy + Cardiac Rehab
Primary Outcome Measures
NameTimeMethod
Proportion of Completers12 weeks

Proportion of screened eligible participants who complete the initial 2-hour psychosocial support session intake.

The pilot study is considered feasible if the primary endpoint is met in at least 50% of patients. We will evaluate the 95% CI of the feasibility rate.

Secondary Outcome Measures
NameTimeMethod
Difference of General Anxiety Disorder-7 (GAD-7) score12 weeks
Difference of Functional Assessment of Cancer Therapy-Prostate (FACT-P) score12 weeks
Difference in Patient Health Questionnaire-9 (PHQ-9)12 weeks

Trial Locations

Locations (1)

Stanford University

🇺🇸

Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath